This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
The Secop MP2UVULTM compressor is designed for mobile refrigeration systems that require extremely low temperatures to safely transport biomaterials such as CGTs (cell and gene therapies) and mRNA-based vaccines for COVID-19 and Ebola.
Secop’s MP2UVULT compressor, which is part of its ULT product series, supports temperatures ranging from -94° F to -122° F (-70° C to -86° C), regardless of outside temperatures. The compressor operates with battery and solar power, eliminating the need for a power grid.
The MP2UVULTM is suitable for 21 to 42 qt (20 to 40 L) cooling containers and, unlike other systems, requires no dry ice. This feature brings environmental benefits and facilitates distribution in remote areas where water is in short supply.
Secop’s ULT products are certified by the World Health Organization (WHO) and are designed to be compatible with ethane (R170) refrigerant.
In addition to the MP2UVULTM compressor for mobile use, Secop’s ULT compressor series includes four other compressors for stationary use. All compressors in this line can be used for ultra-low temperatures as well as biomedical applications with temperatures ranging from -22° F to -76° F (-30° C to -60° C). Secop’s ULT refrigeration compressors for stationary use are available in the entire global voltage range. This broad range is suitable for refrigerated containers with volumes from 21 to 211 qt (20 to 200 L) and from 211 to 528 qt (200 to 500 L).
